Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 16, 2020 - Issue
Submit an article Journal homepage
176
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study

Srihari Gopal1 Janssen Research and Development, LLC, Titusville, NJ, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5254-2192
ORCID Icon,
Jagadish Gogate1 Janssen Research and Development, LLC, Titusville, NJ, USA
,
Katalin Pungor2 Medical Affairs, EMEA, Janssen-Cilag, Neuss, GermanyORCID Iconhttps://orcid.org/0000-0003-4679-2050
ORCID Icon,
Edward Kim3 Janssen Scientific Affairs, Janssen Pharmaceuticals, Titusville, NJ, USAORCID Iconhttps://orcid.org/0000-0001-8247-6675
ORCID Icon,
Arun Singh1 Janssen Research and Development, LLC, Titusville, NJ, USAORCID Iconhttps://orcid.org/0000-0002-9567-6139
ORCID Icon &
Maju Mathews1 Janssen Research and Development, LLC, Titusville, NJ, USA
Pages 681-690 | Published online: 06 Mar 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.